MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-20-0013583
Hari Ganesh Pharma Private Limited
Hari Ganesh Pharma Private Limited - pharma in Noida, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹6.13 Cr
▲ 11% YoY
Net profit · FY 2025
₹7.25 Lakh
Net margin 1.2%
EBITDA · FY 2025
₹14.46 Lakh
EBITDA margin 2.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
Active GSTINs
2
GST registered
About Hari Ganesh Pharma Private Limited
Data last updated:
Hari Ganesh Pharma Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74999UP2020PTC130119. Its GSTIN is 36AAFCH3077G1ZK (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Chandrasekaran Hariharan Chitoor and Hari C Ganesh.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 14B Sector – 62, Noida, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.13 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹7.25 Lakh (net margin 1.2%) and EBITDA of ₹14.46 Lakh (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years.
Hari Ganesh Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0013583).
Company details
CIN U74999UP2020PTC130119
Registration Number 130119
Incorporation Date 30 June 2020
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-20-0013583
Key People
Chandrasekaran Hariharan Chitoor Director Hari C Ganesh Director Chandrasekaran Aditya Director Recognitions & Rankings of Hari Ganesh Pharma
Contact details
Hari Ganesh Pharma Private Limited's registered office is in Noida, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressB – 14B Sector – 62, Noida, Uttar Pradesh, India – 201301
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Hari Ganesh Pharma Private Limited, buy the company report.
Comprehensive company report
Hari Ganesh Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activities of Hari Ganesh Pharma are professional, scientific and technical and trade. In detail, this covers other professional, scientific and technical activities and retail trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | |
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Hari Ganesh Pharma Private Limited, buy the company report.
Financials of Hari Ganesh Pharma Private Limited
FY 2025 filings availableHari Ganesh Pharma Private Limited reported revenue of ₹6.13 Cr (up 11% YoY) for FY 2025.
Revenue · FY 2025
₹6.13 Cr ▲ 11%
Net profit · FY 2025
₹7.25 Lakh margin 1.2%
EBITDA · FY 2025
₹14.46 Lakh margin 2.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▲ 6%
3 years · compounded
▼ 4%
Revenue has grown at a compounded annual rate (CAGR) of 14% over three years, including 11% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.46 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.25 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hari Ganesh Pharma Private Limited, buy the company report.
Board of directors of Hari Ganesh Pharma Private Limited
Hari Ganesh Pharma has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandrasekaran Hariharan Chitoor | Director | 30 Jun 2020 | 6 Years 3 Months | Current |
| Hari C Ganesh | Director | 30 Jun 2020 | 6 Years 3 Months | Current |
| Chandrasekaran Aditya | Director | 05 Aug 2024 | 2 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Hari Ganesh Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hari Ganesh Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hari Ganesh Pharma has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCH3077G1ZK | Telangana | Active | 30 Jul 2020 |
| 36AAFCH3077G2ZJ | Telangana | Active | 08 Oct 2020 |
To see the full GST registrations and return filing status of Hari Ganesh Pharma Private Limited, buy the company report.
Recent activity
Hari Ganesh Pharma Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Chandrasekaran Aditya was appointed as Director on 05 Aug 2024.
AGM
Hari Ganesh Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Hari Ganesh Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh Ii.
Appointed
Chandrasekaran Aditya was appointed as Director.
Appointed
Chandrasekaran Hariharan Chitoor was appointed as Director.
Appointed
Hari C Ganesh was appointed as Director.
Incorporation
30 Jun 2020
Hari Ganesh Pharma Private Limited was registered on 30 Jun 2020 with Roc Uttar Pradesh Ii & aged 6 years 4 months as per MCA records.
Frequently asked questions
Hari Ganesh Pharma is an active private limited company based in Noida, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 June 2020 (6+ years old) and is registered under CIN U74999UP2020PTC130119.
Hari Ganesh Pharma has 3 current directors:
- Chandrasekaran Hariharan Chitoor - Director
- Hari C Ganesh - Director
- Chandrasekaran Aditya - Director
The latest financial statements of Hari Ganesh Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Hari Ganesh Pharma is 36AAFCH3077G1ZK, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 36AAFCH3077G2ZJ (Telangana).
The CIN (Corporate Identification Number) of Hari Ganesh Pharma is U74999UP2020PTC130119. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hari Ganesh Pharma was incorporated on 30 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Chandrasekaran Aditya was appointed as Director on 05 Aug 2024. Chandrasekaran Hariharan Chitoor was appointed as Director on 30 Jun 2020. Hari C Ganesh was appointed as Director on 30 Jun 2020.
Yes, Hari Ganesh Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0013583).
The registered office of Hari Ganesh Pharma is at B – 14B Sector – 62, Noida, Uttar Pradesh, India – 201301.
Hari Ganesh Pharma operates in the pharma industry, in the drug formulation and development segment.